RDHL
Redhill Biopharma
RDHL
RDHL
34 hedge funds and large institutions have $64.8M invested in Redhill Biopharma in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 36 → 34 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
34
Holding in Top 10
2
Calls
$194K
Puts
$14K
Top Buyers
1 | +$307K | |
2 | +$190K | |
3 | +$58.2K | |
4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$41.5K |
5 |
Bank of New York Mellon
New York
|
+$41.5K |
Top Sellers
1 | -$1.68M | |
2 | -$892K | |
3 | -$303K | |
4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$287K |
5 |
MC
Menta Capital
San Francisco,
California
|
-$218K |